Scaling up manufacturing for allogeneic cell therapies

Allogeneic cell therapies present opportunities for scalable manufacturing but require careful process design, quality control, and operational planning. This session examines practical approaches to increase throughput, maintain product consistency, and prepare for large-scale production. 

Key takeaways 

• Outline strategies for scaling allogeneic cell therapy manufacturing 

• Discuss approaches to maintain product quality and batch consistency 

• Evaluate process design considerations for higher throughput 

• Explore integration of quality systems and regulatory compliance 

• Review operational models that support commercial-scale production